GENE ONLINE|News &
Opinion
Blog

Feature
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
Researchers now completed the largest zebrafish genome atlas to date, opening up new avenues for biomedical research. Zebrafish, while they are a popular model organism for research due to their transparent embryo growth and unusual regenerative properties, have lacked a systematic and functional annotation database similar to other model animals.
2022-07-05
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Special
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
France-headquartered healthcare giant, Sanofi, announced on July 4 that it is launching a global health brand called Impact to distribute 30 Sanofi-produced medicines in 40 low-income countries on a non-profit basis. The Impact brand will include standard-of-care medicines like insulin, glibenclamide, oxaliplatin, and others, in addition to a $25 million fund to support local healthcare services and training for medicine administration. 
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
The fate of Sandoz, a generic and biosimilar arm of Novartis, remains hanging in the air after several months of discussion regarding what to do with the underperforming part of the larger company. The rumor mill continues churning as talks of a spinoff are now the topic of conversation after several potential private equity purchases never came to fruition. 
2022-07-04
Roe Reversal May Cause Downstream Issues in Repurposing Mifepristone
The Supreme Court of the United State’s decision to end the constitutional right to abortions (Roe v. Wade) has garnered attention for one of America’s most common abortion-inducing drugs, mifepristone. The drug, originally FDA approved in 2002 for use inducing pregnancy termination, has shown promise in other treatment areas like cancer, hormonal diseases, and mental health disorders. However, because individual states determine abortion laws now, access to mifepristone may be restricted for research purposes even outside of pregnancy termination. 
2022-06-27
LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
Deals
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
Blueprint Medicines Gathers Up To $1.25 Billion in Loans and Investments for Research and Development
2022-07-01
These Pharma Companies Are Laying Off Employees Due to Restructuring
2022-06-30
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
F-star Therapeutics Signs On to invoX Pharma for $161 Million to Stay Afloat
2022-06-24
EQT and Mubadala to Acquire Envirotainer in $3 Billion Deal
2022-06-08
Ranking & Reports
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
2022-03-09
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
Categories
Refining Psychedelics into Medicine – An Interview with Doug Drysdale, CEO of Cybin
2022-04-19
The Renaissance of Psychedelics Research: An Interview with the CEO of MindMed, Rob Barrow
2022-04-12
Sudden Death in Infants Could Have a Genetic Basis
2022-03-29
Takeda Reveals Positive Data on Takhzyro at EAACI
2022-07-01
ASEAN Health Officials to Establish Regional CDC Following COVID-19
2022-05-18
P&G Health dons the Purple Ribbon to commemorate Neuropathy Awareness Week
2022-05-17
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
FDA Halts Sanofi’s $3.7B Multiple Sclerosis Investment
2022-07-01
Takeda Reveals Positive Data on Takhzyro at EAACI
2022-07-01
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Innovent, Lilly’s PD-1 Inhibitor Approved to Treat Esophageal Cancer in China
2022-06-21
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
US Bio-Entrepreneur Program Launches in the UK
2022-06-30
Ultima Genomics Promises $100 Genome After Raising $600 Million
2022-06-01
REVEAL GENOMICS and Dana-Farber Cancer Institute Team Up to Research Breast Cancer
2022-04-29
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Spying Rapid Growth, Avantor Invests in Manufacturing Hub in Singapore
2022-05-05
Bayer Focuses on Strengthening its Global Pharmaceuticals Production Network
2022-04-08
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
Astellas and Sutro Team Up for Immunostimulatory Antibody-Drug Conjugates (iADCs)
2022-06-28
Amgen Out-Licenses Two Therapies to Fosun Pharma to Expand Presence in China
2022-06-28
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
Fat Away from the Land: 3rd Generation Biodiesel
2022-06-29
Saudi Arabia to Invest $3.4 Billion in Latest Push to Develop Biotechnology Presence
2022-06-29
Brain Freeze, Iceland Based Pharma Company Gets Funding for ADHD R&D
2022-06-24
This One-Time Injection Could Cure AIDS
2022-06-21
Why CRY2 matters: Studying Control of Plants and Human Growth
2022-06-20
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top